These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 24754084)
1. [Recent advances in our understanding of the molecular mechanisms of liver fibrosis]. Tu C; Wang J Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):5-8. PubMed ID: 24754084 [No Abstract] [Full Text] [Related]
2. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery. Bian EB; Zhao B; Huang C; Wang H; Meng XM; Wu BM; Ma TT; Zhang L; Lv XW; Li J Cell Signal; 2013 Sep; 25(9):1837-44. PubMed ID: 23707524 [TBL] [Abstract][Full Text] [Related]
3. Cytogenetic studies in Indian childhood cirrhosis. Verma IC; Ghai OP; Chawla V Indian J Pediatr; 1971 Mar; 38(278):125-7. PubMed ID: 5124007 [No Abstract] [Full Text] [Related]
4. Fibrosis in the liver: acute protection and chronic disease. Lee Y; Friedman SL Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733 [TBL] [Abstract][Full Text] [Related]
13. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Marcolongo M; Young B; Dal Pero F; Fattovich G; Peraro L; Guido M; Sebastiani G; Palù G; Alberti A Hepatology; 2009 Oct; 50(4):1038-44. PubMed ID: 19676127 [TBL] [Abstract][Full Text] [Related]
14. The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Pradat P; Trepo E; Potthoff A; Bakshi R; Young B; Trepo C; Lagier R; Moreno C; Lemmers A; Gustot T; Degre D; Adler M; Wedemeyer H Hepatology; 2010 Jan; 51(1):356-7. PubMed ID: 19824080 [No Abstract] [Full Text] [Related]
16. Analysis of proteins dominantly expressed in hepatic stellate cells of activated phenotype. Kawada N Methods Mol Med; 2005; 117():371-9. PubMed ID: 16118463 [TBL] [Abstract][Full Text] [Related]
17. [A molecular genetic analysis in 2 children with congenital hepatic fibrosis]. Harris PR; Cavagnaro S M F Rev Med Chil; 2008 Jun; 136(6):815-6. PubMed ID: 18769842 [No Abstract] [Full Text] [Related]
18. Cirrhosis and constitutional telomerase mutations. Hiriart JB; Bioulac-Sage P; Balabaud C Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):607-9. PubMed ID: 21978439 [TBL] [Abstract][Full Text] [Related]
20. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]